New Leaf Venture Partners, L.L.C. Avrobio, Inc. Transaction History

New Leaf Venture Partners, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	BUY	$14.12 - $23.44 $1.41 Million - $2.34 Million	100,000 Added 46.39%	315,550 $4.46 Million
Q4 2018 Feb 13, 2019	BUY	$15.43 - $32.7 $666,576 - $1.41 Million	43,200 Added 25.07%	215,550 $3.59 Million
Q3 2018 Nov 13, 2018	BUY	$26.95 - $52.7 $602,332 - $1.18 Million	22,350 Added 14.9%	172,350 $8.94 Million
Q2 2018 Aug 14, 2018	BUY	$28.08 - $31.2 $4.21 Million - $4.68 Million	150,000 New	150,000 $4.28 Million

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of New Leaf Venture Partners, L.L.C., based on Form 13F filings with the SEC.

Stay updated on New Leaf Venture Partners, L.L.C. with notifications on news.